7Baggers
 Form 424B5 FENNEC PHARMACEUTICALS  StreetInsider Mon, 17 Nov 2025 11:38:57 GMT
 wedbush on fennec pharmaceuticals' q3  MarketScreener Fri, 14 Nov 2025 16:17:29 GMT
 Fennec Pharmaceuticals Sells Shares To Raise $35 Million  Finimize Fri, 14 Nov 2025 15:57:22 GMT
 Fennec Pharmaceuticals Prices US$35 Million Share Offering at US$7.50  MarketScreener Fri, 14 Nov 2025 11:22:30 GMT
 Fennec Pharmaceuticals Sector Update and Therapeutic Focus  Kalkine Media Fri, 14 Nov 2025 09:22:00 GMT
 Fennec Pharmaceuticals prices $35 million public offering By Investing.com  Investing.com Nigeria Fri, 14 Nov 2025 07:22:38 GMT
 Fennec Pharmaceuticals : November 2025 Canadian Private Offering  MarketScreener Fri, 14 Nov 2025 05:00:07 GMT
 Fennec Pharmaceuticals Announces Pricing of Offering of Common Shares  The Manila Times Fri, 14 Nov 2025 04:25:13 GMT
 Fennec Pharmaceuticals announces common shares offering By Investing.com  Investing.com Nigeria Fri, 14 Nov 2025 03:11:41 GMT
 Fennec’s Record Revenue Isn’t Enough To Satisfy Investors  Finimize Fri, 14 Nov 2025 01:42:12 GMT
 Fennec Pharmaceuticals Q3 Loss Narrows as Pedmark Sales Hit Record  MarketScreener Thu, 13 Nov 2025 21:43:43 GMT
 Fennec Pharmaceuticals announces common shares offering By Investing.com  Investing.com UK Thu, 13 Nov 2025 21:18:00 GMT
 (FENC) Movement as an Input in Quant Signal Sets  news.stocktradersdaily.com Wed, 12 Nov 2025 12:56:02 GMT
 (FRX) Risk-Controlled Trading Report (FRX:CA)  news.stocktradersdaily.com Mon, 10 Nov 2025 21:11:38 GMT
 (FRX) Strategic Equity Report (FRX:CA)  news.stocktradersdaily.com Fri, 07 Nov 2025 23:48:22 GMT
 Insider Sell: Rosty Raykov Sells 10,000 Shares of Fennec Pharmac  GuruFocus Fri, 07 Nov 2025 00:08:43 GMT
 (FRX) Trading Advice (FRX:CA)  news.stocktradersdaily.com Wed, 05 Nov 2025 02:38:40 GMT

Fennec Pharmaceuticals Inc
(NASDAQ:FENC) 

FENC stock logo

Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product PEDMARK, a formulation of Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced heari...

Full Time Employees: 4
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends